Pyridine, 4-[4-(4-methylphenyl)-2-thiazolyl]-2-propyl-, 98%, 250mg

Volumetric flasks with glass stopper, class A Brown glass, 50 ml, 14/23, 2 Piece(s)

3-(Bromomethyl)-2-cyclopropyl-4-(4-fluorophenyl)quinoline, 95.0%, 10g

6-Bromo-2-ethyl-2,3-dihydro-1h-isoindol-1-one, 97%, 100mg

1-ethyl-6-fluoro-4-oxo-7-piperazin-1-yl-1,4-dihydroquinoline-3-carboxylic acid, 95.0%, 500g

tert-Butyl 5,6,8,9-tetrahydro-7H-imidazo[1,2-d][1,4]diazepine-7-carboxylate, 95%, 100mg

2-Methyl-5-nitro-1,3-benzoxazole, 97.0%, 10g

9-Bromo-10-[4-(1-naphthyl)phenyl]anthracene>98.0%(HPLC)200mg

tert-Butyl 4-(2-amino-2-oxoethyl)piperidine-1-carboxylate, 95.0%, 100mg

TERT-BUTYL (4R,6R)-2-[6-[2-[2-(4-FLUOROPHENYL)-5-ISOPROPYL-3-PHENYL-4-(PHENYLCARBAMOYL)PYRROL-1-YL]ETHYL]-2,2-DIMETHYL-1,3-DIOXAN-4-YL]ACETATE, 98%, 500g

3-Chloro-4,4-dimethylpent-2-enenitrile, 5g

4-(Difluoromethoxy)benzaldehyde, 98.0%, 10g

4-(Piperidin-4-ylmethyl)benzamide hydrochloride, 95.0%, 100mg